• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    58 Biggest Movers From Yesterday

    12/17/21 4:43:57 AM ET
    $ADBE
    $ADGI
    $AGFY
    $AI
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADBE alert in real time by email

    Gainers

    • Adagio Therapeutics, Inc. (NASDAQ:ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price target from Jefferies.
    • Kaixin Auto Holdings (NASDAQ:KXIN) surged 36.3% to close at $1.69 after the company announced an agreement with Bujia, which agreed to order at least 10,000 new energy trucks from Kaixin in the next five years.
    • Assertio Holdings, Inc. (NASDAQ:ASRT) surged 23.7% to close at $1.67 after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.
    • Aptose Biosciences Inc. (NASDAQ:APTO) gained 23.5% to settle at $1.47. Aptose Biosciences recently reported HM43239 data featured in an oral presentation at the ASH Annual Meeting.
    • Calliditas Therapeutics AB (NASDAQ:CALT) shares jumped 22.3% to close at $22.93 on Thursday after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.
    • Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) surged 21.1% to close at $43.00 after reporting new data and providing additional updates from ARCT-154 and ARCT-165 clinical trials.
    • Zai Lab Limited (NASDAQ:ZLAB) climbed 20.7% to close at $66.26 after the company announced China has approved NUZYRA as a category 1 innovative drug for the treatment of community acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
    • Datasea Inc. (NASDAQ:DTSS) gained 20.3% to settle at $1.54.
    • X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) rose 17.3% to close at $2.37. X4 Pharmaceuticals recently presented new clinical and scientific data at the 2021 ASH Annual Meeting.
    • Splash Beverage Group, Inc. (NYSE:SBEV) gained 17.3% to settle at $1.22. Splash Beverage Group recently engaged TraDigital IR as its digital communication provider.
    • Mechel PAO (NYSE:MTL) jumped 16.9% to close at $3.11.
    • Nexters Inc. (NASDAQ:GDEV) gained 16.7% to settle at $8.75.
    • Purple Innovation, Inc. (NASDAQ:PRPL) jumped 16.6% to close at $10.90. Purple Innovation recently said it anticipates FY21 net sales and adjusted EBITDA at the low end of the prior guidance ranges.
    • New Found Gold Corp. (NYSE:NFGC) rose 15.9% to settle at $6.21.
    • Valneva SE (NASDAQ:VALN) gained 15.6% to close at $58.95 after the company announced results from the homologous booster data in the Phase 1/2 study confirm that VLA2001 significantly boosted immunity in participants who received VLA2001 as a primary vaccination.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) surged 15.4% to settle at $4.58. Cabaletta Bio recently said its DSG3-CAART failed to show biologic activity to date in the two lowest cell dose cohorts of Phase 1 trial mucosal Pemphigus Vulgaris (mPV).
    • Euro Tech Holdings Company Limited (NASDAQ:CLWT) gained 15.4% to close at $3.38.
    • Alpha Pro Tech, Ltd. (NYSE:APT) gained 14.6% to settle at $6.13. Alpha Pro Tech recently added $2 million to its buyback program.
    • Cadiz Inc. (NASDAQ:CDZI) jumped 13.6% to close at $4.26.
    • CooTek (Cayman) Inc. (NYSE:CTK) climbed 11.8% to close at $0.54 after dropping more than 10% on Wednesday.
    • Stryve Foods, Inc. (NASDAQ:SNAX) gained 11.3% to close at $3.74 following news of deals for the expansion of its domestic US distribution and product line penetration with Costco and Walmart.
    • Doma Holdings Inc. (NYSE:DOMA) jumped 10.1% to settle at $5.43.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) gained 9.8% to close at $1.68 after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.
    • Engine Gaming and Media, Inc. (NASDAQ:GAME) rose 8.4% to close at $3.10.
    • Jowell Global Ltd. (NASDAQ:JWEL) rose 8.1% to close at $19.10. Jowell Global recently posted Q3 sales of $43.80 million.
    • MoneyLion Inc. (NYSE:ML) rose 7.8% to settle at $3.73 as the company announced plans to acquire Even Financial for up to $440 million.
    • Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) gained 7.3% to close at $3.08 after gaining over 4% on Wednesday.
    • HUTCHMED (China) Limited (NASDAQ:HCM) gained 6.3% to close at $33.92.
    • Retail Value Inc. (NYSE:RVI) rose 4.6% to close at $6.34 after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.

     

    Check out these big penny stock gainers and losers

    Losers

    • Bakkt Holdings, Inc. (NASDAQ:BKKT) shares dipped 34% to settle at $9.08 on Thursday after the company reported a mixed shelf offering.
    • IronNet, Inc. (NASDAQ:IRNT) shares fell 31.5% to close at $4.66 on Thursday after the company said Q3 sales results were lower year over year. Needham downgraded IronNet from Buy to Hold.
    • uniQure N.V. (NASDAQ:QURE) fell 29.6% to close at $20.24 after the company reported clinical update on first patients in Phase I/II clinical trial of AMT-130 gene therapy for the treatment of Huntington's disease.
    • Aerovate Therapeutics, Inc. (NASDAQ:AVTE) dropped 25.9% to settle at $9.14. Aerovate Therapeutics recently announced the initiation of its IMPAHCT Phase 2b/Phase 3 trial of AV-101 In Pulmonary Arterial Hypertension.
    • P3 Health Partners Inc. (NASDAQ:PIII) fell 21.5% to settle at $8.74.
    • Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) declined 21% to close at $9.94.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) fell 20.4% to close at $3.27. Ensysce Biosciences said that the first patients have been enrolled in Phase 1 study of PF614-MPAR, its unique technology platform to provide opioid overdose protection.
    • Danimer Scientific, Inc. (NYSE:DNMR) shares declined 20.1% to close at $8.46 after the company reported a proposed convertible senior notes offering.
    • East Stone Acquisition Corporation (NASDAQ:ESSC) declined 19.8% to settle at $12.22.
    • Bird Global, Inc. (NYSE:BRDS) fell 19.2% to close at $7.25.
    • Terawulf Inc. (NASDAQ:WULF) dropped 16.9% to settle at $16.23. TeraWulf recently said it has completed previously-announced business combo deal with IKONICS.
    • InnSuites Hospitality Trust (NYSE:IHT) declined 16.2% to close at $2.27.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) fell 13.7% to close at $2.40. Quoin Pharma recently announced an exclusive distribution agreement with Orpharm LLC for QRX003.
    • Regional Health Properties, Inc. (NYSE:RHE) fell 19.7% to settle at $5.38. Regional Health Props, last month, posted Q3 loss of $1.25 per share.
    • MiNK Therapeutics, Inc. (NASDAQ:INKT) dropped 18.7% to close at $4.39.
    • Agrify Corporation (NASDAQ:AGFY) fell 17.8% to close at $10.34.
    • Flexsteel Industries, Inc. (NASDAQ:FLXS) dropped 16.5% to settle at $24.68. Flexsteel Industries raised its Q2 sales guidance from 130 million-$140 million to $137 million -$143 million.
    • Xilio Therapeutics, Inc. (NASDAQ:XLO) fell 15% to settle at $9.89.
    • Muscle Maker, Inc. (NASDAQ:GRIL) fell 14.9% to close at $0.8932.
    • Ambarella, Inc. (NASDAQ:AMBA) declined 14.3% to close at $179.63.
    • Entrada Therapeutics, Inc. (NASDAQ:TRDA) fell 14.2% to settle at $15.35 after the company reported Q3 EPS were lower year over year.
    • Endo International plc (NASDAQ:ENDP) declined 14.1% to close at $3.71 after Barclays lowered its price target from $7 to $5.
    • Volcon, Inc. (NASDAQ:VLCN) shares dropped 13.9% to settle at $8.74. Volcon recently announced dealership agreement with Nash Powersports.
    • Sprout Social, Inc. (NASDAQ:SPT) shares declined 13.9% to close at $82.04 after Morgan Stanley lowered its price target on the stock from $146 to $110.
    • IsoPlexis Corporation (NASDAQ:ISO) fell 13.9% to close at $6.02.
    • Unity Biotechnology, Inc. (NASDAQ:UBX) dipped 12.5% to settle at $1.54.
    • Doximity, Inc. (NASDAQ:DOCS) fell 11.5% to settle at $49.32.
    • Adobe Inc. (NASDAQ:ADBE) dropped 10.2% to close at $566.09 after the company issued Q1 and FY22 EPS and sales guidance below analyst estimates.
    • C3.ai, Inc. (NYSE:AI) fell 9.9% to close at $31.54 after Morgan Stanley maintained an Underweight rating on the stock and lowered its price target from $45 to $31.
    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $ADGI
    $AGFY
    $AI

    CompanyDatePrice TargetRatingAnalyst
    Doximity Inc.
    $DOCS
    2/6/2026$40.00Underweight → Neutral
    Analyst
    Adobe Inc.
    $ADBE
    2/3/2026$330.00Overweight → Neutral
    Piper Sandler
    CADIZ Inc.
    $CDZI
    2/2/2026$10.00Buy
    Maxim Group
    Entrada Therapeutics Inc.
    $TRDA
    1/28/2026$21.00Outperform
    Oppenheimer
    uniQure N.V.
    $QURE
    1/28/2026$31.00Equal Weight
    Barclays
    Arcturus Therapeutics Holdings Inc.
    $ARCT
    1/23/2026$20.00Buy
    Roth Capital
    Doximity Inc.
    $DOCS
    1/20/2026$55.00Equal Weight → Overweight
    Wells Fargo
    Adobe Inc.
    $ADBE
    1/13/2026Outperform → Perform
    Oppenheimer
    More analyst ratings

    $ADBE
    $ADGI
    $AGFY
    $AI
    SEC Filings

    View All

    SEC Form S-8 filed by GameSquare Holdings Inc.

    S-8 - GameSquare Holdings, Inc. (0001714562) (Filer)

    2/6/26 5:02:19 PM ET
    $GAME
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    GameSquare Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - GameSquare Holdings, Inc. (0001714562) (Filer)

    2/6/26 4:05:59 PM ET
    $GAME
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Splash Beverage Group Inc. (NV) filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SPLASH BEVERAGE GROUP, INC. (0001553788) (Filer)

    2/6/26 8:13:57 AM ET
    $SBEV
    Beverages (Production/Distribution)
    Consumer Staples

    $ADBE
    $ADGI
    $AGFY
    $AI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XOLREMDI issued to X4 PHARMACEUTICALS INC

    Submission status for X4 PHARMACEUTICALS INC's drug XOLREMDI (ORIG-1) with active ingredient MAVORIXAFOR has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218709, Application Classification: Type 1 - New Molecular Entity

    4/29/24 2:36:51 PM ET
    $XFOR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for TARPEYO issued to CALLIDITAS THERAPEUTICS AB

    Submission status for CALLIDITAS THERAPEUTICS AB's drug TARPEYO (ORIG-1) with active ingredient BUDESONIDE has changed to 'Approval' on 12/15/2021. Application Category: NDA, Application Number: 215935, Application Classification: Type 5 - New Formulation or New Manufacturer

    12/20/21 3:40:41 PM ET
    $CALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ADGI
    $AGFY
    $AI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Chang David J. bought $19,888 worth of shares (8,800 units at $2.26) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:58 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President, Science & Tech. Binder Gwendolyn bought $24,763 worth of shares (11,312 units at $2.19), increasing direct ownership by 57% to 31,312 units (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:30 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Tomasello Shawn bought $50,322 worth of shares (22,725 units at $2.21) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:55:49 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADBE
    $ADGI
    $AGFY
    $AI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Doximity upgraded by Analyst with a new price target

    Analyst upgraded Doximity from Underweight to Neutral and set a new price target of $40.00

    2/6/26 8:05:27 AM ET
    $DOCS
    EDP Services
    Technology

    Adobe downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Adobe from Overweight to Neutral and set a new price target of $330.00

    2/3/26 6:51:31 AM ET
    $ADBE
    Computer Software: Prepackaged Software
    Technology

    Maxim Group initiated coverage on Cadiz with a new price target

    Maxim Group initiated coverage of Cadiz with a rating of Buy and set a new price target of $10.00

    2/2/26 7:47:52 AM ET
    $CDZI
    Water Supply
    Utilities

    $ADBE
    $ADGI
    $AGFY
    $AI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Baes Nicholas decreased direct ownership by 5% to 101,023 units (SEC Form 5)

    5 - Bakkt, Inc. (0001820302) (Issuer)

    2/6/26 7:02:42 PM ET
    $BKKT
    Finance: Consumer Services
    Finance

    Director Wampler Kira Scherer converted options into 2,000 shares and sold $74,660 worth of shares (2,000 units at $37.33) (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    2/4/26 4:11:16 PM ET
    $DOCS
    EDP Services
    Technology

    Executive Chairman Siebel Thomas M converted options into 53,125 shares, sold $298,410 worth of shares (27,605 units at $10.81), gifted 25,520 shares and received a gift of 25,520 shares (SEC Form 4)

    4 - C3.ai, Inc. (0001577526) (Issuer)

    2/3/26 9:26:29 PM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ADGI
    $AGFY
    $AI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

    ~ Supraphysiological expression of α-Gal A activity maintained for over a year in longest treated patient as of data cutoff date ~ ~ Stable Lyso-Gb3 levels maintained post-dosing, regardless of enzyme replacement therapy status across all cohorts ~ ~ Six of 11 patients have discontinued enzyme replacement therapy as of data cutoff date ~ LEXINGTON, Mass. and AMSTERDAM, Feb. 06, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced updated preliminary safety and exploratory efficacy data from 11 patients in its Phase I/IIa trial of AMT-191, an investigational AAV gene

    2/6/26 7:05:00 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HUTCHMED to Announce 2025 Final Results

    HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Feb. 06, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM: HCM; SEHK:13) will be announcing its final results for the year ended December 31, 2025 on Thursday, March 5, 2026 at 6:00 am Eastern Standard Time (EST) / 11:00 am Greenwich Mean Time (GMT) / 7:00 pm Hong Kong Time (HKT). HUTCHMED management will host two webcast presentations for analysts and investors to discuss the final results, followed by Q&A sessions. The English webcast will be held on Thursday, March 5, 2026, at 8:00 am EST (1:00 pm GMT / 9:00 pm HKT). The Chinese (Putonghua) webcast will be held at 8:30 am HKT / 12:30 am GMT on Friday, March 6, 202

    2/6/26 3:30:00 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ambarella Announces Fourth Quarter and Fiscal Year 2026 Earnings Conference Call to be Held February 26, 2026

    SANTA CLARA, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ambarella, Inc. (NASDAQ:AMBA), an edge AI semiconductor company, today announced it will hold its fourth quarter and fiscal year 2026 earnings conference call on Thursday, February 26, 2026 at 1:30 p.m. (Pacific Time). The company will issue its earnings release after the market closes that same day. Those interested in asking a question on the call are required to register online in advance. Upon completing the first step of the online registration process, please note a registration verification code will be emailed to you, and this code must be entered to complete the online registration process. Once registered and verified, the d

    2/5/26 8:00:00 PM ET
    $AMBA
    Semiconductors
    Technology

    $ADBE
    $ADGI
    $AGFY
    $AI
    Leadership Updates

    Live Leadership Updates

    View All

    Dave O'Hara Joins Cadiz Board of Directors

    Former Microsoft Commercial CFO brings decades of experience in corporate finance and commercial strategy LOS ANGELES, Feb. 4, 2026 /PRNewswire/ -- Cadiz, Inc. (NASDAQ:CDZI, the ", Company", )) announced today that Mr. Dave O'Hara, a senior finance executive with extensive experience in corporate finance, commercial strategy and large-scale growth initiatives, has joined the Company's Board of Directors. Mr. O'Hara spent more than 20 years at Microsoft in senior executive leadership roles, most recently serving as Executive Vice President and Chief Financial Officer of Microso

    2/4/26 9:46:00 AM ET
    $CDZI
    Water Supply
    Utilities

    Bakkt Agrees to Acquire Distributed Technologies Research Ltd.

    - Acquisition advances Bakkt's global stablecoin settlement and programmable payments strategy- Company to operate as "Bakkt, Inc." effective January 22, 2026- Investor Day scheduled for March 17, 2026 at the New York Stock Exchange NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bakkt Holdings, Inc. ("Bakkt" or the "Company") (NYSE:BKKT) today announced that it has agreed to acquire Distributed Technologies Research Ltd. ("DTR"), a global stablecoin payment infrastructure provider. Pursuant to the definitive agreement, and as consideration for DTR, Bakkt will issue shares of its Class A common stock representing 31.5% of the "Bakkt Share Number," as defined in the previously announced Coope

    1/12/26 8:00:00 AM ET
    $BKKT
    Finance: Consumer Services
    Finance

    Mike Clayville Joins C3 AI Board of Directors

    C3 AI (NYSE:AI), the Enterprise AI application software company, today announced the appointment of Mike Clayville to its board of directors, effective November 9, 2025. Mr. Clayville brings over 30 years of enterprise software and cloud infrastructure expertise. Most recently, he served as Chief Customer Officer at Stripe. Before Stripe, he led global commercial sales at Amazon Web Services, overseeing operations serving millions of customers across 170 countries. Earlier in his career, Mr. Clayville held senior leadership roles at VMware, BEA Systems, Tivoli Systems, and IBM, leading large-scale digital transformation initiatives. "Mike has spent his career helping companies grow an

    11/13/25 9:00:00 AM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ADGI
    $AGFY
    $AI
    Financials

    Live finance-specific insights

    View All

    Ambarella Announces Fourth Quarter and Fiscal Year 2026 Earnings Conference Call to be Held February 26, 2026

    SANTA CLARA, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ambarella, Inc. (NASDAQ:AMBA), an edge AI semiconductor company, today announced it will hold its fourth quarter and fiscal year 2026 earnings conference call on Thursday, February 26, 2026 at 1:30 p.m. (Pacific Time). The company will issue its earnings release after the market closes that same day. Those interested in asking a question on the call are required to register online in advance. Upon completing the first step of the online registration process, please note a registration verification code will be emailed to you, and this code must be entered to complete the online registration process. Once registered and verified, the d

    2/5/26 8:00:00 PM ET
    $AMBA
    Semiconductors
    Technology

    Flexsteel Industries, Inc. Reports Strong Fiscal Second Quarter 2026 Results

    Flexsteel Industries, Inc. (NASDAQ:FLXS) ("Flexsteel" or the "Company"), one of the largest manufacturers, importers, and marketers of residential furniture products in the United States, today reported second quarter fiscal 2026 results. Key Results for the Second Quarter Ended December 31, 2025 Net sales for the quarter of $118.2 million compared to $108.5 million in the prior year quarter, an increase of 9.0%. GAAP operating income of $9.0 million or 7.6% of net sales compared to $11.7 million or 10.7% of net sales in the prior year quarter. Adjusted operating income of $9.0 million or 7.6% of net sales for the second quarter compared to $6.7 million or 6.1% of net sales in the

    2/2/26 4:10:00 PM ET
    $FLXS
    Home Furnishings
    Consumer Discretionary

    IHT DECLARES 56TH CONSECUTIVE ANNUAL DIVIDEND AS HOTEL REVENUES SURGE

    Phoenix, AZ, Jan. 21, 2026 (GLOBE NEWSWIRE) -- InnSuites Hospitality Trust (NYSE:IHT) On January 12, 2026, the Board of Trustees of InnSuites Hospitality Trust (NYSE Am: IHT), announced a semi-annual dividend of $0.01 per share payable on February 9, 2026, to shareholders of record as of January 27, 2026, extending an uninterrupted continuous 56-year history of annual dividends. InnSuites Hotel operations continue to remain strong, with a combined revenue total in December for the two hotels of $536,399. We are also pleased to report record revenues for the two hotels combined for the month of December 2025, and project record hotel total Revenues for our IHT hotels for the 2026 Fiscal Ye

    1/21/26 5:27:00 PM ET
    $IHT
    Investment Bankers/Brokers/Service
    Finance

    $ADBE
    $ADGI
    $AGFY
    $AI
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Led to the Purchase at Aerovate Therapeutics Inc. on Jun 20?

    Recently, on June 20, 2024, a notable insider purchase was made at Aerovate Therapeutics Inc. Director Ra Capital Management, L.P. bought $1,549,944 worth of shares, acquiring 928,110 units at $1.67 per share as reported in the SEC Form 4. Insider transactions like these are closely watched by investors as they can provide valuable insights into the company's prospects. When analyzing insider transactions, it is essential to look for patterns and trends among multiple transactions to gauge the overall sentiment within the company. Several other SEC Form 4 filings were made around the same time, on June 7, 2024, by various insiders at Aerovate Therapeutics Inc. These included transactions by

    6/21/24 3:23:59 PM ET
    $AVTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Insider Analysis: Purchase at Assertio Holdings Inc. on Jun 6

    Recent insider transactions at Assertio Holdings Inc. have brought attention to the company's stock activity. On June 6, 2024, Mason Heather L purchased $24,250 worth of shares, acquiring 25,000 units at $0.97 per share. This transaction increased Mason Heather L's direct ownership by 13% to 212,650 units, as reported in the SEC Form 4. Several other notable insider transactions have taken place at Assertio Holdings Inc. leading up to this purchase. Patel Ajay, Schwichtenberg Paul, and Schlessinger Sam all converted options into shares and covered exercise/tax liability by utilizing their shares. These transactions resulted in ownership increases of 16%, 20%, and 21%, respectively. Addition

    6/10/24 1:20:50 AM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ADGI
    $AGFY
    $AI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MoneyLion Inc.

    SC 13D/A - MONEYLION INC. (0001807846) (Subject)

    12/10/24 5:27:46 PM ET
    $ML
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by CADIZ Inc.

    SC 13G/A - CADIZ INC (0000727273) (Subject)

    12/6/24 6:52:25 PM ET
    $CDZI
    Water Supply
    Utilities

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care